Overview

We are a real estate investment trust ("REIT") that commenced operations in 1986. We invest in healthcare and human service related facilities currently including acute care hospitals, behavioral health care hospitals, specialty hospitals, free-standing emergency departments, childcare centers and medical/office buildings. As of February 25, 2021, we have seventy-two real estate investments or commitments in twenty states consisting of:

• seven hospital facilities consisting of three acute care, one behavioral

health care and three specialty hospitals (two of which are currently


        vacant);


  • four free-standing emergency departments ("FEDs");


    •   fifty-seven medical/office buildings, including five owned by
        unconsolidated LLCs/LPs, and;


  • four preschool and childcare centers.

Forward Looking Statements



This report contains "forward-looking statements" that reflect our current
estimates, expectations and projections about our future results, performance,
prospects and opportunities. Forward-looking statements include, among other
things, information concerning our possible future results of operations,
business and growth strategies, financing plans, expectations that regulatory
developments or other matters will not have a material adverse effect on our
business or financial condition, our competitive position and the effects of
competition, the projected growth of the industry in which we operate, and the
benefits and synergies to be obtained from our completed and any future
acquisitions, and statements of our goals and objectives, and other similar
expressions concerning matters that are not historical facts. Words such as
"may," "will," "should," "could," "would," "predicts," "potential," "continue,"
"expects," "anticipates," "future," "intends," "plans," "believes," "estimates,"
"appears," "projects" and similar expressions, as well as statements in future
tense, identify forward-looking statements.

Forward-looking statements should not be read as a guarantee of future
performance or results, and will not necessarily be accurate indications of the
times at, or by which, such performance or results will be achieved.
Forward-looking information is based on information available at the time and/or
our good faith belief with respect to future events, and is subject to risks and
uncertainties that could cause actual performance or results to differ
materially from those expressed in the statements. Such factors include, among
other things, the following:

• Future operations and financial results of our tenants, and in turn ours,

will likely be materially impacted by numerous factors and future

developments related to COVID-19. Such factors and developments include,

but are not limited to, the length of time and severity of the spread of

the pandemic; the volume of cancelled or rescheduled elective procedures

and the volume of COVID-19 patients treated by the operators of our

hospitals and other healthcare facilities; measures our tenants are taking


        to respond to the COVID-19 pandemic; the impact of government and
        administrative regulation, including travel bans and restrictions,
        shelter-in-place or stay-at-home orders, quarantines, the promotion of
        social distancing, business shutdowns and limitations on business

activity; changes in patient volumes at our tenants' hospitals and other

healthcare facilities due to patients' general concerns related to the

risk of contracting COVID-19 from interacting with the healthcare system;

the impact of stimulus on the health care industry and our tenants;

changes in patient volumes and payer mix caused by deteriorating

macroeconomic conditions (including increases in uninsured and

underinsured patients as the result of business closings and layoffs);

potential disruptions to clinical staffing and shortages and disruptions

related to supplies required for our tenants' employees and patients,

including equipment, pharmaceuticals and medical supplies, particularly

personal protective equipment, or PPE; potential increases to expenses

incurred by our tenants related to staffing, supply chain or other

expenditures; the impact of our indebtedness and the ability to refinance


        such indebtedness on acceptable terms; disruptions in the financial
        markets and the business of financial institutions as the result of the
        COVID-19 pandemic which could impact our ability to access capital or

increase associated borrowing costs; and changes in general economic

conditions nationally and regionally in the markets our properties are

located resulting from the COVID-19 pandemic, including higher sustained

rates of unemployment and underemployment levels and reduced consumer

spending and confidence. There may be significant declines in future bonus

rental revenue earned on our hospital properties leased to subsidiaries of

UHS to the extent that each hospital continues to experience significant

decline in patient volumes and revenues. These factors may result in the

inability or unwillingness on the part of some of our tenants to make

timely payment of their rent to us at current levels or to seek to amend

or terminate their leases which, in turn, would have an adverse effect on


        our occupancy levels and our revenue and cash flow and the value of our
        properties, and potentially, our ability to maintain our dividend at
        current levels.




                                       33

--------------------------------------------------------------------------------





    •   Due to COVID-19 restrictions and its impact on the economy, we may

experience a decrease in prospective tenants which could unfavorably

impact the volume of new leases, as well as the renewal rate of existing


        leases. The COVID-19 pandemic may delay our construction projects which
        could result in increased costs and delay the timing of opening and rental

payments from those projects, although no such delays have yet occurred.

The COVID-19 pandemic could also impact our indebtedness and the ability

to refinance such indebtedness on acceptable terms, as well as risks

associated with disruptions in the financial markets and the business of

financial institutions as the result of the COVID-19 pandemic which could

impact us from a financing perspective; and changes in general economic


        conditions nationally and regionally in the markets our properties are
        located resulting from the COVID-19 pandemic. Recently, COVID-19
        vaccinations have begun to be administered and while we expect that

administration of vaccines will assist in easing the number of COVID-19

cases, the pace at which this is likely to occur is difficult to predict.

Although COVID-19 has not had a material adverse impact on our financial

results during 2020, we believe that developments related to the COVID-19

pandemic may potentially have a material adverse impact on our future


        financial results.




    •   Recent legislation, including the Coronavirus Aid, Relief, and Economic

Security Act (the "CARES Act") and the Paycheck Protection Program and

Health Care Enhancement Act ("PPPHCE Act"), has provided grant funding to

hospitals and other healthcare providers to assist them during the

COVID-19 pandemic. There is a high degree of uncertainty surrounding the

implementation of the CARES Act and the PPPHCE Act, and the federal

government may consider additional stimulus and relief efforts, but we are

unable to predict whether additional stimulus measures will be enacted or

their impact. There can be no assurance as to the total amount of

financial and other types of assistance our tenants will receive under the

CARES Act and the PPPHCE Act, and it is difficult to predict the impact of

such legislation on our tenants' operations or how they will affect

operations of our tenants' competitors. Moreover, we are unable to assess

the extent to which anticipated negative impacts on our tenants (and, in

turn, us) arising from the COVID-19 pandemic will be offset by amounts or

benefits received or to be received under the CARES Act and the PPPHCE

Act.

• A substantial portion of our revenues are dependent upon one operator,

UHS, which comprised approximately 33%, 31% and 30% of our consolidated

revenues for the years ended December 31, 2020, 2019 and 2018,

respectively. We cannot assure you that subsidiaries of UHS will renew the

leases on our three acute care hospitals (two of which are scheduled to

expire in December, 2021 and one of which is scheduled to expire in

December, 2026) and two FEDs at existing lease rates or fair market value

lease rates. In addition, if subsidiaries of UHS exercise their options to

purchase the respective leased hospital facilities and FEDs upon

expiration of the lease terms or otherwise, our future revenues and

results of operations could decrease if we were unable to earn a favorable


        rate of return on the sale proceeds received, as compared to the rental
        revenue currently earned pursuant to these leases. Please see Note 4 to

the consolidated financial statements - Lease Accounting, for additional

information related to a potential transaction with a wholly-owned

subsidiary of UHS in connection with Southwest Healthcare System, Inland

Valley Campus.

• In certain of our markets, the general real estate market has been

unfavorably impacted by increased competition/capacity and decreases in


        occupancy and rental rates which may adversely impact our operating
        results and the underlying value of our properties.

• A number of legislative initiatives have recently been passed into law

that may result in major changes in the health care delivery system on a

national or state level to the operators of our facilities, including UHS.

No assurances can be given that the implementation of these new laws will

not have a material adverse effect on the business, financial condition or

results of operations of our operators.

• The potential indirect impact of the Tax Cuts and Jobs Act of 2017, signed


        into law on December 22, 2017, which makes significant changes to
        corporate and individual tax rates and calculation of taxes, which could
        potentially impact our tenants and jurisdictions, both positively and

negatively, in which we do business, as well as the overall investment

thesis for REITs.

• A subsidiary of UHS is our Advisor and our officers are all employees of a


        wholly-owned subsidiary of UHS, which may create the potential for
        conflicts of interest.


    •   Lost revenues resulting from the exercise of purchase options, lease
        expirations and renewals and other transactions (see Note 4 to the
        consolidated financial statements - Lease Accounting for additional
        disclosure related to lease expirations and subsequent vacancies that

occurred during the second and third quarters of 2019 on two hospital

facilities.

• Our ability to continue to obtain capital on acceptable terms, including

borrowed funds, to fund future growth of our business.

• The outcome and effects of known and unknown litigation, government

investigations, and liabilities and other claims asserted against us, UHS


        or the other operators of our facilities. UHS and its subsidiaries are
        subject to legal actions,




                                       34

--------------------------------------------------------------------------------

purported shareholder class actions and shareholder derivative cases,

governmental investigations and regulatory actions and the effects of

adverse publicity relating to such matters. Since UHS comprised

approximately 33% of our consolidated revenues during the year ended

December 31, 2020, and since a subsidiary of UHS is our Advisor, you are


        encouraged to obtain and review the disclosures contained in the Legal
        Proceedings section of Universal Health Services, Inc.'s Forms 10-Q and

10-K, as publicly filed with the Securities and Exchange Commission. Those


        filings are the sole responsibility of UHS and are not incorporated by
        reference herein.

• Failure of UHS or the other operators of our hospital facilities to comply

with governmental regulations related to the Medicare and Medicaid

licensing and certification requirements could have a material adverse

impact on our future revenues and the underlying value of the property.

• The potential unfavorable impact on our business of the deterioration in

national, regional and local economic and business conditions, including a

further worsening of credit and/or capital market conditions, which may

adversely affect our ability to obtain capital which may be required to


        fund the future growth of our business and refinance existing debt with
        near term maturities.

• A continuation in the deterioration in general economic conditions which

has resulted in increases in the number of people unemployed and/or

insured and likely increase the number of individuals without health

insurance; as a result, the operators of our facilities may experience

declines in patient volumes which could result in decreased occupancy

rates at our medical office buildings.

• A continuation of the worsening of the economic and employment conditions


        in the United States will likely materially affect the business of our
        operators, including UHS, which will likely unfavorably impact our future
        bonus rentals (on the UHS hospital facilities) and may potentially have a

negative impact on the future lease renewal terms and the underlying value

of the hospital properties.

• Real estate market factors, including without limitation, the supply and

demand of office space and market rental rates, changes in interest rates

as well as an increase in the development of medical office condominiums

in certain markets.

• The impact of property values and results of operations of severe weather

conditions, including the effects of hurricanes.

• Government regulations, including changes in the reimbursement levels

under the Medicare and Medicaid programs.

• The issues facing the health care industry that affect the operators of

our facilities, including UHS, such as: changes in, or the ability to

comply with, existing laws and government regulations; unfavorable changes


        in the levels and terms of reimbursement by third party payors or
        government programs, including Medicare (including, but not limited to,
        the potential unfavorable impact of future reductions to Medicare

reimbursements and Medicaid reimbursements (most states have reported

significant budget deficits that have, in the past, resulted in the

reduction of Medicaid funding to the operators of our facilities,

including UHS); demographic changes; the ability to enter into managed

care provider agreements on acceptable terms; an increase in uninsured and

self-pay patients which unfavorably impacts the collectability of patient

accounts; decreasing in-patient admission trends; technological and

pharmaceutical improvements that may increase the cost of providing, or

reduce the demand for, health care, and; the ability to attract and retain

qualified medical personnel, including physicians.

• Pending limits for most federal agencies and programs aimed at reducing

budget deficits by $917 billion between 2012 and 2021, according to a

report released by the Congressional Budget Office. Among its other

provisions, the law resulted in across-the-board cuts to discretionary,

national defense and Medicare spending on March 1, 2013, including

Medicare payment reductions of up to 2% per fiscal year with a uniform

percentage reduction across all Medicare programs. The Bipartisan Budget

Act of 2015, enacted on November 2, 2015, continued these 2% reductions to

Medicare reimbursement. The CARES Act suspended payment reductions between

May 1 and December 31, 2020, in exchange for extended cuts through

2030. The CAA extended the suspension of payment reductions until March

31, 2021. We cannot predict whether Congress will restructure the

implemented Medicare payment reductions or what other federal budget

deficit reduction initiatives may be proposed by Congress going

forward. We also cannot predict the effect these enactments will have on

the operators of our properties (including UHS), and thus, our business.

• An increasing number of legislative initiatives have been passed into law


        that may result in major changes in the health care delivery system on a
        national or state level. Legislation has already been enacted that has
        eliminated the penalty for failing to maintain health coverage that was
        part of the original Patient Protection and Affordable Care Act and

Healthcare and Education Reconciliation Act of 2010 (collectively referred

to as the "Legislation"). President Biden is expected to undertake

executive actions that will strengthen the Legislation and may reverse the

policies of the prior administration. The Trump Administration had

directed the issuance of final rules (i) enabling the formation of

association health plans that would be exempt from certain Legislation


        requirements such as the provision of essential health benefits; (ii)
        expanding the availability of short-term, limited duration health
        insurance, (iii) eliminating cost-sharing reduction




                                       35

--------------------------------------------------------------------------------

payments to insurers that would otherwise offset deductibles and other

out-of-pocket expenses for health plan enrollees at or below 250 percent

of the federal poverty level; (iv) relaxing requirements for state

innovation waivers that could reduce enrollment in the individual and

small group markets and lead to additional enrollment in short-term,

limited duration insurance and association health plans; (v) incentivizing

the use of health reimbursement arrangements by employers to permit

employees to purchase health insurance in the individual market, and; (vi)


        directing the issuance of federal rulemaking by executive agencies to
        increase transparency of healthcare price and quality information. The
        uncertainty resulting from these Executive Branch policies has led to

reduced Exchange enrollment in 2018 and 2019 and is expected to further

worsen the individual and small group market risk pools in future

years. It is also anticipated that these policies, to the extent that they

remain as implemented, may create additional cost and reimbursement

pressures on hospitals, including ours. In addition, while attempts to

repeal the entirety of the Legislation have not been successful to date, a

key provision of the Legislation was repealed as part of the Tax Cuts and

Jobs Act and on December 14, 2018, a federal U.S. District Court Judge in

Texas ruled the entire Legislation is unconstitutional. That ruling was

stayed and has been appealed. On December 18, 2019, the 5th Circuit Court

of Appeals voted 2-1 to strike down the Legislation individual mandate as

unconstitutional and sent the case back to the U.S. District Court in

Texas to determine which Legislation provisions should be stricken with

the mandate. On March 2, 2020, the U.S. Supreme Court agreed to hear,

during the 2020-2021 term, two consolidated cases, filed by the State of

California and the United States House of Representatives, asking the

Supreme Court to review the ruling by the Fifth Circuit Court of Appeals.

Oral argument was heard on November 10, 2020, and a ruling is expected in

2021. On February 10, 2021, the Department of Justice announced that it

has withdrawn support for the challenge before the Supreme Court. We are

unable to predict the final outcome of this matter which has caused

greater uncertainty regarding the future status of the Legislation. If all

or any parts of the Legislation are ultimately found to be

unconstitutional, it could have a material adverse effect on the business,


        financial condition and results of operations of the operators of our
        properties, and, thus, our business.

• Under the Legislation, hospitals are required to make public a list of

their standard charges, and effective January 1, 2019, CMS has required

that this disclosure be in machine-readable format and include charges for

all hospital items and services and average charges for diagnosis-related

groups. On November 27, 2019, CMS published a final rule on "Price

Transparency Requirements for Hospitals to Make Standard Charges Public."

This rule took effect on January 1, 2021 and requires all hospitals to

also make public their payor-specific negotiated rates, minimum negotiated

rates, maximum negotiated rates, and cash for all items and services,


        including individual items and services and service packages, that could
        be provided by a hospital to a patient. Failure to comply with these
        requirements may result in daily monetary penalties.

• As part of the CAA, Congress passed legislation aimed at preventing or


        limiting patient balance billing in certain circumstances. The CAA
        addresses surprise medical bills stemming from emergency services,
        out-of-network ancillary providers at in-network facilities, and air
        ambulance carriers. The legislation prohibits surprise billing when
        out-of-network emergency services or out-of-network services at an

in-network facility are provided, unless informed consent is received. In

these circumstances providers are prohibited from billing the patient for

any amounts that exceed in-network cost-sharing requirements. The

legislation requires implementing regulations within a year of enactment.

• There can be no assurance that if any of the announced or proposed changes

described above are implemented there will not be negative financial


        impact on the operators of our hospitals, which material effects may
        include a potential decrease in the market for health care services or a

decrease in the ability of the operators of our hospitals to receive

reimbursement for health care services provided which could result in a

material adverse effect on the financial condition or results of

operations of the operators of our properties, and, thus, our business.

• Competition for properties include, but are not limited to, other REITs,

private investors and firms, banks and other companies, including UHS. In

addition, we may face competition from other REITs for our tenants.

• The operators of our facilities face competition from other health care

providers, including physician owned facilities and other competing

facilities, including certain facilities operated by UHS but the real

property of which is not owned by us. Such competition is experienced in

markets including, but not limited to, McAllen, Texas, the site of our

McAllen Medical Center, a 370-bed acute care hospital, and Riverside

County, California, the site of our Southwest Healthcare System-Inland

Valley Campus, a 130-bed acute care hospital.

• Changes in, or inadvertent violations of, tax laws and regulations and


        other factors than can affect REITs and our status as a REIT.



• The individual and collective impact of the changes made by the CARES Act

on REITs and their security holders are uncertain and may not become

evident for some period of time; it is also possible additional

legislation could be enacted in the future as a result of the COVID-19


        pandemic which may affect the holders of our securities.




                                       36

--------------------------------------------------------------------------------

• Should we be unable to comply with the strict income distribution


        requirements applicable to REITs, utilizing only cash generated by
        operating activities, we would be required to generate cash from other
        sources which could adversely affect our financial condition.

• Our ownership interest in five LLCs/LPs in which we hold non-controlling


        equity interests. In addition, pursuant to the operating and/or
        partnership agreements of the four LLCs/LPs in which we continue to hold
        non-controlling ownership interests, the third-party member and the Trust,

at any time, potentially subject to certain conditions, have the right to

make an offer ("Offering Member") to the other member(s) ("Non-Offering

Member") in which it either agrees to: (i) sell the entire ownership

interest of the Offering Member to the Non-Offering Member ("Offer to

Sell") at a price as determined by the Offering Member ("Transfer Price"),

or; (ii) purchase the entire ownership interest of the Non-Offering Member

("Offer to Purchase") at the equivalent proportionate Transfer Price. The

Non-Offering Member has 60 to 90 days to either: (i) purchase the entire


        ownership interest of the Offering Member at the Transfer Price, or;
        (ii) sell its entire ownership interest to the Offering Member at the

equivalent proportionate Transfer Price. The closing of the transfer must

occur within 60 to 90 days of the acceptance by the Non-Offering Member.




  • Fluctuations in the value of our common stock.


    •   Other factors referenced herein or in our other filings with the
        Securities and Exchange Commission.


Given these uncertainties, risks and assumptions, you are cautioned not to place
undue reliance on such forward-looking statements. Our actual results and
financial condition, including the operating results of our lessees and the
facilities leased to subsidiaries of UHS, could differ materially from those
expressed in, or implied by, the forward-looking statements.

Forward-looking statements speak only as of the date the statements are made. We
assume no obligation to publicly update any forward-looking statements to
reflect actual results, changes in assumptions or changes in other factors
affecting forward-looking information, except as may be required by law. All
forward-looking statements attributable to us or persons acting on our behalf
are expressly qualified in their entirety by this cautionary statement.

Critical Accounting Policies and Estimates



The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires us to make estimates
and assumptions that affect the amounts reported in our consolidated financial
statements and accompanying notes.

We consider our critical accounting policies to be those that require us to make
significant judgments and estimates when we prepare our financial statements,
including the following:

Purchase Accounting for Acquisition of Investments in Real Estate: Purchase
accounting is applied to the assets and liabilities related to all real estate
investments acquired from third parties. In accordance with current accounting
guidance, we account for our property acquisitions as acquisitions of assets,
which requires the capitalization of acquisition costs to the underlying assets
and prohibits the recognition of goodwill or bargain purchase gains. The fair
value of the real estate acquired is allocated to the acquired tangible assets,
consisting primarily of land, building and tenant improvements, and identified
intangible assets and liabilities, consisting of the value of above-market and
below-market leases, and acquired ground leases, based in each case on their
fair values. Loan premiums, in the case of above market rate assumed loans, or
loan discounts, in the case of below market assumed loans, are recorded based on
the fair value of any loans assumed in connection with acquiring the real
estate.



The fair values of the tangible assets of an acquired property are determined
based on comparable land sales for land and replacement costs adjusted for
physical and market obsolescence for the improvements. The fair values of the
tangible assets of an acquired property are also determined by valuing the
property as if it were vacant, and the "as-if-vacant" value is then allocated to
land, building and tenant improvements based on management's determination of
the relative fair values of these assets. Management determines the as-if-vacant
fair value of a property based on assumptions that a market participant would
use, which is similar to methods used by independent appraisers. In addition,
there is intangible value related to having tenants leasing space in the
purchased property, which is referred to as in-place lease value. Such value
results primarily from the buyer of a leased property avoiding the costs
associated with leasing the property and also avoiding rent losses and
unreimbursed operating expenses during the hypothetical lease-up period. Factors
considered by management in performing these analyses include an estimate of
carrying costs during the expected lease-up periods considering current market
conditions and costs to execute similar leases. In estimating carrying costs,
management includes real estate taxes, insurance and other operating expenses
and estimates of lost rental revenue during the expected lease-up periods based
on current market demand. Management also estimates costs to execute similar
leases including leasing commissions, tenant improvements, legal and other
related costs. The value of in-place leases are amortized to expense over the
remaining initial terms of the respective leases.



                                       37

--------------------------------------------------------------------------------




In allocating the fair value of the identified intangible assets and liabilities
of an acquired property, above-market and below-market in-place lease values are
recorded based on the present value (using an interest rate which reflects the
risks associated with the leases acquired) of the difference between (i) the
contractual amounts to be paid pursuant to the in-place leases and
(ii) estimated fair market lease rates from the perspective of a market
participant for the corresponding in-place leases, measured, for above-market
leases, over a period equal to the remaining non-cancelable term of the lease
and, for below-market leases, over a period equal to the initial term plus any
below market fixed rate renewal periods. The capitalized above-market lease
values are amortized as a reduction of rental income over the remaining
non-cancelable terms of the respective leases. The capitalized below-market
lease values, also referred to as acquired lease obligations, are amortized as
an increase to rental income over the initial terms of the respective leases.

Asset Impairment:  We review each of our properties for indicators that its
carrying amount may not be recoverable. Examples of such indicators may include
a significant decrease in the market price of the property, a change in the
expected holding period for the property, a significant adverse change in how
the property is being used or expected to be used based on the underwriting at
the time of acquisition, an accumulation of costs significantly in excess of the
amount originally expected for the acquisition or development of the property,
or a history of operating or cash flow losses of the property. When such
impairment indicators exist, we review an estimate of the future undiscounted
net cash flows (excluding interest charges) expected to result from the real
estate investment's use and eventual disposition and compare that estimate to
the carrying value of the property. We consider factors such as future operating
income, trends and prospects, as well as the effects of leasing demand,
competition and other factors. If our future undiscounted net cash flow
evaluation indicates that we are unable to recover the carrying value of a real
estate investment, an impairment loss is recorded to the extent that the
carrying value exceeds the estimated fair value of the property. The evaluation
of anticipated cash flows is highly subjective and is based in part on
assumptions regarding future occupancy, rental rates and capital requirements
that could differ materially from actual results in future periods. Since cash
flows on properties considered to be long-lived assets to be held and used are
considered on an undiscounted basis to determine whether the carrying value of a
property is recoverable, our strategy of holding properties over the long-term
directly decreases the likelihood of their carrying values not being recoverable
and therefore requiring the recording of an impairment loss. If our strategy
changes or market conditions otherwise dictate an earlier sale date, an
impairment loss may be recognized and such loss could be material. If we
determine that the asset fails the recoverability test, the affected assets must
be reduced to their fair value.



We generally estimate the fair value of rental properties utilizing a discounted
cash flow analysis that includes projections of future revenues, expenses and
capital improvement costs that a market participant would use based on the
highest and best use of the asset, which is similar to the income approach that
is commonly utilized by appraisers. In certain cases, we may supplement this
analysis by obtaining outside broker opinions of value or third party
appraisals.



In considering whether to classify a property as held for sale, we consider
factors such as whether management has committed to a plan to sell the property,
the property is available for immediate sale in its present condition for a
price that is reasonable in relation to its current value, the sale of the
property is probable, and actions required for management to complete the plan
indicate that it is unlikely that any significant changes will made to the
plan. If all the criteria are met, we classify the property as held for sale.
Upon being classified as held for sale, depreciation and amortization related to
the property ceases and it is recorded at the lower of its carrying amount or
fair value less cost to sell. The assets and related liabilities of the property
are classified separately on the consolidated balance sheets for the most recent
reporting period. Only those assets held for sale that constitute a strategic
shift or that will have a major effect on our operations are classified as
discontinued operations.

An other than temporary impairment of an investment in an unconsolidated LLC is
recognized when the carrying value of the investment is not considered
recoverable based on evaluation of the severity and duration of the decline in
value, including projected declines in cash flow. To the extent impairment has
occurred, the excess carrying value of the asset over its estimated fair value
is charged to income.



Federal Income Taxes:  No provision has been made for federal income tax
purposes since we qualify as a REIT under Sections 856 to 860 of the Internal
Revenue Code of 1986, and intend to continue to remain so qualified.  To qualify
as a REIT, we must meet certain organizational and operational requirements,
including a requirement to distribute at least 90% of our annual REIT taxable
income to shareholders. As a REIT, we generally will not be subject to federal,
state or local income tax on income that we distribute as dividends to our
shareholders.

We are subject to a federal excise tax computed on a calendar year basis. The
excise tax equals 4% of the amount by which 85% of our ordinary income plus 95%
of any capital gain income for the calendar year exceeds cash distributions
during the calendar year, as defined. No provision for excise tax has been
reflected in the financial statements as no tax was due.



                                       38

--------------------------------------------------------------------------------


Earnings and profits, which determine the taxability of dividends to
shareholders, will differ from net income reported for financial reporting
purposes due to the differences for federal tax purposes in the cost basis of
assets and in the estimated useful lives used to compute depreciation and the
recording of provision for investment losses.

Results of Operations

Year ended December 31, 2020 as compared to the year ended December 31, 2019:



For the year ended December 31, 2020, net income was $19.4 million as compared
to $19.0 million during 2019. The $483,000 increase was primarily attributable
to:

$2.04 million decrease resulting from lease expirations on two hospital

facilities located in Corpus Christi, Texas, and Evansville, Indiana, that

occurred on June 1, 2019 and September 30, 2019, respectively (each facility


      has remained vacant since the respective date of lease expiration);

$2.27 million increase resulting from a decrease in interest expense,

primarily due to a decrease in our average cost of borrowings under our

revolving credit agreement, partially offset by an increase in our average

outstanding borrowings;

$1.95 million decrease resulting from gains recorded during 2019 related to

the sale of the Kings Crossing II MOB and the sale of a parcel of land;

$565,000 increase in bonus rentals earned on the three hospital facilities

leased to subsidiaries of UHS;

$289,000 increase resulting from a decrease in depreciation and amortization

expense, and;

$1.35 million of other combined net increases, including increased net

income experienced at various properties.




Total revenues increased $847,000, or 1.1%, during 2020 as compared to 2019. The
increase was due to: (i) an aggregate net increase of $1.71 million experienced
at various properties; (ii) a $565,000 increase in the bonus rentals; (iii) a
$311,000 increase resulting from an MOB that was acquired during the fourth
quarter of 2019, partially offset by; (iv) a $1.74 million decrease resulting
from the revenues recorded during 2019 in connection with two hospital
facilities that had lease expirations and vacancies in June and September of
2019 (see Note 4 to the consolidated financial statements, Lease Accounting).

Included in our other operating expenses are expenses related to the
consolidated medical office buildings and two vacant hospital facilities (as
discussed herein), which totaled $19.8 million and $19.1 million for the years
ended December 31, 2020 and 2019, respectively. Our operating expenses for 2020
and 2019 include expenses associated with the lease expirations at two of our
hospital facilities, which are currently vacant, of approximately $677,000 and
$370,000 in the aggregate for the years ended December 31, 2020 and 2019,
respectively. A large portion of the expenses associated with our consolidated
medical office buildings is passed on directly to the tenants either directly as
tenant reimbursements of common area maintenance expenses of included in base
rental amounts. Tenant reimbursements for operating expenses are accrued as
revenue in the same period the related expenses are incurred and are included as
tenant reimbursement revenue in our consolidated statements of income.

Funds from operations ("FFO") is a widely recognized measure of performance for
Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted
share, which are non-GAAP financial measures, are helpful to our investors as
measures of our operating performance. We compute FFO, as reflected on the
attached Supplemental Schedules, in accordance with standards established by the
National Association of Real Estate Investment Trusts ("NAREIT"), which may not
be comparable to FFO reported by other REITs that do not compute FFO in
accordance with the NAREIT definition, or that interpret the NAREIT definition
differently than we interpret the definition. FFO adjusts for the effects of
gains, such as gains on transactions during the periods presented. To the extent
a REIT recognizes a gain or loss with respect to the sale of incidental assets,
such as the sale of land peripheral to operating properties, the REIT has the
option to exclude or include such gains and losses in the calculation of FFO. We
have opted to exclude gains and losses from sales of incidental assets in our
calculation of FFO. FFO does not represent cash generated from operating
activities in accordance with GAAP and should not be considered to be an
alternative to net income determined in accordance with GAAP. In addition, FFO
should not be used as: (i) an indication of our financial performance determined
in accordance with GAAP; (ii) an alternative to cash flow from operating
activities determined in accordance with GAAP; (iii) a measure of our liquidity,
or; (iv) an indicator of funds available for our cash needs, including our
ability to make cash distributions to shareholders.



                                       39

--------------------------------------------------------------------------------


Below is a reconciliation of our reported net income to FFO for 2020 and 2019
(in thousands):

                                                            2020             2019
Net income                                              $     19,447     $     18,964

Depreciation and amortization expense on consolidated investments

                                                   25,581        

25,870


Depreciation and amortization expense on
unconsolidated affiliates                                      1,202        

1,141


Gains on sales of real estate assets                               -           (1,951 )
Funds From Operations                                   $     46,230     $  

44,024



Weighted average number of shares outstanding -
Diluted                                                       13,765        

13,752


Funds From Operations per diluted share                 $       3.36     $  

3.20




Our FFO increased $2.2 million, or $.16 per diluted share, during 2020 as
compared to 2019 due to: (i) a favorable impact of $2.3 million, or $.17 per
diluted share, resulting from a decrease in interest expense, primarily due to a
decrease in our average cost of borrowings pursuant to our revolving credit
agreement, partially offset by an increase in our average outstanding
borrowings; (ii) a favorable impact of $565,000, or $.04 per diluted share,
resulting from an increase in bonus rentals; (iii) other combined net increases
of $1.4 million, or $.10 per diluted share, partially offset by; (iv) an
unfavorable impact of $2.0 million, or $.15 per diluted share, related to the
above-mentioned vacancies at two of our hospitals as a result of lease
expirations on June 1, 2019 and September 30, 2019 (excluding the related
interest expense impact).

During 2020, we had a total of 39 new or renewed leases related to the medical
office buildings as indicated in Item 2. Properties, in which we have
significant investments, some of which are accounted for by the equity method.
These leases comprised approximately 30% of the aggregate rentable square feet
of these properties (21% related to renewed leases and 9% related to new
leases). During 2019, we had a total of 62 new or renewed leases related to the
medical office buildings, in which we have significant investments, some of
which are accounted for by the equity method. These leases comprised
approximately 24% of the aggregate rentable square feet of these properties (17%
related to renewed leases and 7% related to new leases).

Rental rates, tenant improvement costs and rental concessions vary from property
to property based upon factors such as, but not limited to, the current
occupancy and age of our buildings, local overall economic conditions, proximity
to hospital campuses and the vacancy rates, rental rates and capacity of our
competitors in the market. In connection with lease renewals executed during
each year, the weighted-average rental rates, as compared to rental rates on the
expired leases, decreased by approximately 1% during 2020 and remained
relatively unchanged during 2019. The weighted-average tenant improvement costs
associated with new or renewed leases was approximately $18 and $15 per square
foot during 2020 and 2019, respectively. The weighted-average leasing
commissions on the new and renewed leases commencing during each year was
approximately 3% of base rental revenue over the term of the leases during 2020
and 2% of base rental revenue over the term of the leases during 2019. The
average aggregate value of the tenant concessions, generally consisting of rent
abatements, provided in connection with new and renewed leases commencing during
each year was approximately 0.9% and 0.4% of the future aggregate base rental
revenue over the lease terms during 2020 and 2019, respectively. Rent abatements
were, or will be, recognized in our results of operations under the
straight-line method over the lease term regardless of when payments are due.



                                       40

--------------------------------------------------------------------------------

Year ended December 31, 2019 as compared to the year ended December 31, 2018:

For the year ended December 31, 2019, net income was $19.0 million as compared to $24.2 million during 2018. The $5.2 million decrease was primarily attributable to:

$4.5 million decrease resulting from the Hurricane Harvey related insurance

recovery proceeds received in excess of property damage write-offs recorded

during 2018;

$1.2 million decrease resulting from the Hurricane Harvey related business

interruption insurance recovery proceeds received recorded during 2018,

including approximately $500,000 which related to 2017;

$1.7 million decrease resulting from the income recorded during 2018 in

connection with a lease termination agreement entered into during the second


      quarter of 2018 related to a single tenant MOB located in Texas that
      terminated a lease that was scheduled to expire in July, 2020;

$2.0 million increase resulting from gains recorded during 2019 related to

the sale of the Kings Crossing II MOB and the sale of a parcel of land;

$600,000 increase related to a short-term lease on a hospital facility

located in Evansville, Indiana (lease term of June 1, 2019 through September

30, 2019), that was entered into at a substantially increased lease rate as

compared to the original lease which expired on May 31, 2019;

$434,000 decrease resulting from the June 1, 2019 expiration of a lease on a

hospital facility located in Corpus Christi, Texas;

$563,000 increase in bonus rental revenue related to the UHS hospital

facilities, and;

$581,000 of other combined net decreases, including an increase in interest

expense due primarily to increases in our average outstanding borrowings,

and average cost of borrowings, pursuant to our revolving credit agreement.




Total revenues increased $1.0 million, or 1.3%, during 2019 as compared to 2018.
The increase was due primarily to: (i) a $563,000 increase in the bonus rental
revenue generated on the UHS hospital facilities; (ii) a $718,000 increase
resulting from the increased rental rate in connection with a short-term lease
covering the period of June 1, 2019 through September 30, 2019 on a hospital
facility located in Evansville, Indiana, that was vacated on September 30, 2019
(see Note 4 to the consolidated financial statements, Lease Accounting), and;
(iii) a $428,000 decrease resulting from the June 1, 2019 lease expiration and
tenant vacancy at a hospital facility located in Corpus Christi, Texas, (see
Note 4 to the consolidated financial statements, Lease Accounting).

Included in our other operating expenses are expenses related to the
consolidated medical office buildings and two vacant hospital facilities (as
discussed herein), which totaled $19.1 million and $18.6 million for the years
ended December 31, 2019 and 2018, respectively. Our operating expenses for 2019
include expenses associated with the lease expirations at two of our hospital
facilities, which are currently vacant, of approximately $370,000 in the
aggregate for the year ended December 31, 2019. A large portion of the expenses
associated with our consolidated medical office buildings is passed on directly
to the tenants either directly as tenant reimbursements of common area
maintenance expenses of included in base rental amounts. Tenant reimbursements
for operating expenses are accrued as revenue in the same period the related
expenses are incurred and are included as tenant reimbursement revenue in our
consolidated statements of income.

During 2019, we had a total of 62 new or renewed leases related to the medical
office buildings as indicated in Item 2. Properties, in which we have
significant investments, some of which are accounted for by the equity method.
These leases comprised approximately 24% of the aggregate rentable square feet
of these properties (17% related to renewed leases and 7% related to new
leases). During 2018, we had a total of 34 new or renewed leases related to the
medical office buildings, in which we have significant investments, some of
which are accounted for by the equity method. These leases comprised
approximately 17% of the aggregate rentable square feet of these properties (14%
related to renewed leases and 3% related to new leases).



                                       41

--------------------------------------------------------------------------------


Rental rates, tenant improvement costs and rental concessions vary from property
to property based upon factors such as, but not limited to, the current
occupancy and age of our buildings, local overall economic conditions, proximity
to hospital campuses and the vacancy rates, rental rates and capacity of our
competitors in the market. In connection with lease renewals executed during
each year, the weighted-average rental rates, as compared to rental rates on the
expired leases, remained relatively unchanged during 2019 and decreased 3%
during 2018. The weighted-average tenant improvement costs associated with new
or renewed leases was approximately $15 and $10 per square foot during 2019 and
2018, respectively. The weighted-average leasing commissions on the new and
renewed leases commencing during each year was approximately 2% of base rental
revenue over the term of the leases during 2019 and 4% of base rental revenue
over the term of the leases during 2018. The average aggregate value of the
tenant concessions, generally consisting of rent abatements, provided in
connection with new and renewed leases commencing during each year was
approximately 0.4% and 0.5% of the future aggregate base rental revenue over the
lease terms during 2019 and 2018, respectively. Rent abatements were, or will
be, recognized in our results of operations under the straight-line method over
the lease term regardless of when payments are due.

Below is a reconciliation of our reported net income to FFO for 2019 and 2018
(in thousands):

                                                            2019             2018
Net income                                              $     18,964     $     24,196

Depreciation and amortization expense on consolidated investments

                                                   25,870        

24,337


Depreciation and amortization expense on
unconsolidated affiliates                                      1,141        

1,036

Hurricane insurance recovery proceeds in excess of damaged property write-downs

                                       -           (4,535 )
Gains on sales of real estate assets                          (1,951 )      

-


Funds From Operations                                   $     44,024     $  

45,034



Weighted average number of shares outstanding -
Diluted                                                       13,752        

13,722


Funds From Operations per diluted share                 $       3.20     $       3.28




Our FFO decreased $1.0 million, or $.08 per diluted share, during 2019 as
compared to 2018 due primarily to: (i) a decrease of approximately $1.7 million,
or $.12 per diluted share, resulting from a lease termination agreement entered
into during 2018 on a single-tenant medical office building located in Texas
(this agreement terminated a lease that was scheduled to expire in July, 2020);
(ii) a decrease of approximately $500,000, or $.04 per diluted share, resulting
from business interruption insurance recovery proceeds recorded during 2018 that
related to the period of August through December of 2017; (iii) an increase of
approximately $400,000, or $.03 per diluted share, consisting of non-recurring
repairs and remediation expenses incurred during 2018 at one of our medical
office buildings; (iv) an increase of approximately $563,000, or $.04 per
diluted share, resulting from an increase in bonus rent from UHS hospital
facilities, and; (v) other combined net increase of approximately $275,000, or
$.02 per diluted share.



Hurricane Harvey Impact

In late August 2017, five of our medical office buildings located in the
Houston, Texas area, incurred extensive water damage as a result of Hurricane
Harvey. Until various times during the second quarter of 2018, these properties
were temporarily closed and non-operational as we continued to reconstruct and
restore them to operational condition. As of June 30, 2018, reconstruction on
all of the occupied space in these properties had been completed and operations
had resumed.



During the first quarter of 2018, pursuant to the terms of a global settlement
with our commercial property insurance carrier, we received $5.5 million of
additional insurance recovery proceeds bringing the aggregate hurricane-related
insurance recoveries to $12.5 million. The aggregate insurance recovery
proceeds, which are net of applicable deductibles, covered substantially all of
the costs incurred related to the remediation, repair and reconstruction of each
of these properties as well business interruption recoveries for the lost income
related to each of these properties during the period they were
non-operational.



Included in our financial results for the year ended December 31, 2018 are
hurricane insurance recoveries of approximately $4.5 million consisting of
recovery proceeds in excess of the damaged property write-downs. Additionally,
during 2018, we recorded approximately $1.2 million of hurricane business
interruption insurance recoveries in connection with the damage sustained from
Hurricane Harvey. Included in this amount, which covered the period of late
August, 2017 through the second quarter of 2018 (after satisfaction of the
applicable deductibles), was approximately $500,000 related to the period of
August, 2017 through December, 2017.






                                       42

--------------------------------------------------------------------------------



Other Operating Results



Interest Expense:

Reflected below are the components of our interest expense which amounted to
$8.3 million during 2020, $10.5 million during 2019 and $10.0 million during
2018 (amounts in thousands):


                                             2020            2019           2018
Revolving credit agreement                  $ 4,608        $  7,551        $ 6,834
Mortgage interest                             2,600           2,701          2,821
Interest rate caps income, net                    -            (122 ) (a.)    (288 ) (a.)
Interest rate swaps expense/(income), net       737   (b.)     (108 ) (c.)  

-


Amortization of financing fees                  765             637         

648


Amortization of fair value of debt              (52 )           (52 )          (50 )
Capitalized interest on major projects         (395 )           (74 )            -
Other interest                                    -               -             12
Interest expense, net                       $ 8,263        $ 10,533        $ 9,977


      (a.) Represents interest paid to us by the counterparties pursuant to two
           interest rate caps with a combined notional amount of $60 million,
           which expired in March 2019.

(b.) Represents net interest paid by us to the counterparties pursuant to


           three interest rates SWAPs with a combined notional amount of $140
           million.

(c.) Represents net interest paid to us by the counterparties pursuant to an


           interest rates SWAPs with a notional amount of $50 million.


Interest expense decreased $2.27 million during 2020 to $8.26 million as
compared to $10.53 million during 2019. The decrease was primarily due to: (i) a
$2.9 million decrease in the interest expense on our revolving credit agreement
resulting from a decrease in our average cost of borrowings pursuant to our
revolving credit agreement (1.8% during 2020 as compared to 3.5% during 2019),
partially offset by an increase in our average outstanding borrowings ($219.1
million during 2020 as compared to $198.3 million during 2019); (ii) a $967,000
net increase in interest expense related to interest rate swaps/caps; (iii) a
$101,000 decrease in mortgage interest expense, resulting primarily from the
repayment of a mortgage loan during the second quarter of 2019; (iv) a $321,000
decrease in interest expense due to an increase in capitalized interest on major
projects, due primarily to the increased construction cost expenditures made
during 2020 made in connection with the Clive Behavioral Health facility, and;
(v) a $128,000 increase due to an increase in amortization of financing fees.

Interest expense increased $556,000 during 2019 to $10.53 million as compared to
$9.98 million during 2018. The increase was primarily due to: (i) a $717,000
increase in interest expense on our revolving credit agreement resulting from an
increase in our average cost of borrowings pursuant to our revolving credit
agreement (3.5% during 2019 as compared to 3.3% during 2018), as well as an
increase in our average outstanding borrowings ($198.3 million during 2019 as
compared to $191.4 million during 2018); (ii) a $58,000 net increase in interest
expense related to interest rate swaps/caps; (iii) a $120,000 decrease in
mortgage interest expense, resulting primarily from the repayment of a mortgage
loans during 2018 and 2019, and; (iv) $99,000 of other combined net decreases in
interest expense.



COVID-19 Impact

The COVID-19 pandemic began to significantly impact the United States in
mid-March, 2020. As a result of various policies implemented by the federal and
state governments, and varying by individual state, many non-essential
businesses in the nation were closed for varying time periods. We believe that
by June 30, 2020, substantially all of our tenants had resumed operations of
their businesses.

Tenants representing approximately 99% of our occupied square footage have paid
their rents through December 31, 2020. Although COVID-19 has not had a material
adverse impact on our results of operations through December 31, 2020, we
believe that the potentially adverse impact that the pandemic may have on our
future operations and financial results of our tenants, and in turn ours, will
depend upon many factors, most of which are beyond our, or our tenants', ability
to control or predict. Since the underlying businesses in each of our properties
are operated by the tenants, we can provide no assurance that the businesses
will continue to operate in the future, or stay current with their lease
obligations.

Since the bonus rents earned by us on the three acute care hospitals leased to
wholly-owned subsidiaries of Universal Health Services, Inc., are computed based
upon a computation that compares each hospital's current quarter revenue to the
corresponding quarter in the base year, we could experience significant declines
in future bonus rental revenue earned on these properties should those hospitals
experience significant declines in patient volumes and revenues. These hospitals
believe that, to the extent that they experience revenue declines and increased
expenses resulting from the COVID-19 pandemic, as ultimately measured over the
life of the pandemic, they are eligible for emergency fund grants as provided
for by the Coronavirus Aid, Relief, and Economic Security Act



                                       43

--------------------------------------------------------------------------------


("CARES Act"). Our financial statements for the year ended December 31, 2020
include bonus rental attributable to revenues recorded by these three hospitals
in connection with CARES Act grants.



Throughout the common areas of many properties in our portfolio, we have
implemented COVID-19 risk mitigating actions such as, enhanced cleaning
protocols including supplemental cleaning and sanitizing of high-touch points,
limiting points of entry at certain facilities, and coordinating with health
care providers to assess or screen patients prior to entering certain of our
MOBs.


Disclosures Related to Certain Hospital Facilities

Please refer to Note 4 to the consolidated financial statements - Lease Accounting, for additional information regarding certain of our hospital facilities including Southwest Healthcare System, Inland Valley Campus; Evansville, Indiana; Corpus Christi, Texas, and; Kindred Hospital Chicago Central.





Effects of Inflation

Inflation has not had a material impact on our results of operations over the
last three years. However, since the healthcare industry is very labor intensive
and salaries and benefits are subject to inflationary pressures, as are supply
and other costs, we and the operators of our hospital facilities cannot predict
the impact that future economic conditions may have on our/their ability to
contain future expense increases. Depending on general economic and labor market
conditions, the operators of our hospital facilities may experience unfavorable
labor market conditions, including a shortage of nurses which may cause an
increase in salaries, wages and benefits expense in excess of the inflation
rate. Their ability to pass on increased costs associated with providing
healthcare to Medicare and Medicaid patients is limited due to various federal,
state and local laws which have been enacted that, in certain cases, limit their
ability to increase prices. Therefore, there can be no assurance that these
factors will not have a material adverse effect on the future results of
operations of the operators of our facilities which may affect their ability to
make lease payments to us.

Most of our leases contain provisions designed to mitigate the adverse impact of
inflation. Our hospital leases require all building operating expenses,
including maintenance, real estate taxes and other costs, to be paid by the
lessee. In addition, certain of the hospital leases contain bonus rental
provisions, which require the lessee to pay additional rent to us based on
increases in the revenues of the facility over a base year amount. In addition,
most of our MOB leases require the tenant to pay an allocable share of operating
expenses, including common area maintenance costs, insurance and real estate
taxes. These provisions may reduce our exposure to increases in operating costs
resulting from inflation. To the extent that some leases do not contain such
provisions, our future operating results may be adversely impacted by the
effects of inflation.

Liquidity and Capital Resources

Year ended December 31, 2020 as compared to December 31, 2019:

Net cash provided by operating activities

Net cash provided by operating activities was $44.2 million during 2020 as compared to $42.7 million during 2019. The $1.6 million net increase was attributable to:

• A favorable change of $2.5 million due to an increase in net income

plus/minus the adjustments to reconcile net income to net cash provided by

operating activities (depreciation and amortization, amortization related to


      above/below market leases, amortization of debt premium, amortization of
      deferred financing costs, stock-based compensation and gains on sales of
      real estate assets), as discussed above;

• an unfavorable change of $710,000 in accrued expenses and other liabilities


      due to the timing of disbursements;


  • a favorable change of $295,000 in lease receivables;

• a favorable change of $182,000 in tenant reserves, deposits and deferred and


      prepaid rents, and;


  • other combined net unfavorable changes of $704,000.




                                       44

--------------------------------------------------------------------------------

Net cash used in investing activities

Net cash used in investing activities was $27.2 million during 2020 as compared to $16.5 million during 2019.

2020:

During 2020, $27.2 million of net cash was used in investing activities as follows:

• spent $28.3 million for additions to real estate investments, including

$22.2 million of construction costs related to a newly constructed, 100-bed

behavioral health care hospital located in Clive, Iowa, that was

substantially completed and received a temporary certificate of occupancy


       in late December, 2020, and tenant improvements at various MOBs;


  • spent $3.2 million in equity investments in unconsolidated LLCs;

• spent $2.3 million on the acquisition of the Sand Point Medical Properties

building in late December 2020, as discussed in Note 3 to the consolidated

financial statements - New Construction, Acquisitions and Dispositions,

and;

• received $6.5 million of cash in excess of income from LLCs, including $5.2


       million of cash proceeds generated from a construction loan obtained by
       Grayson Properties II during the second quarter of 2020.

2019:

During 2019, $16.5 million of net cash was used in investing activities as follows:

• spent $2.1 million to fund equity investments in unconsolidated LLCs/LPs;




     •  spent approximately $12.3 million for capital additions to real estate
        investments, including $5.9 million related to the construction of the
        above-mentioned facility located in Clive, Iowa, as well as tenant
        improvements at various MOBs;

• spent approximately $5.1 million to acquire the Bellin Health Family

Medicine Center, as discussed in Note 3 to the consolidated financial

statements - New Construction, Acquisitions and Dispositions;

• received $318,000 of cash distributions in excess of income received from

our unconsolidated LLCs ($2.1 million of cash distributions received less

$1.8 million of equity in income of unconsolidated LLCs), and;

• received approximately $2.8 million of combined cash proceeds from the

sales of real estate assets consisting of an MOB located in Kingwood,

Texas, and a parcel of land.



Net cash used in financing activities

Net cash used in financing activities was $17.4 million during 2020, as compared to $25.1 million during 2019.

2020:

The $17.4 million of cash used in financing activities during 2020 consisted primarily of:

• paid $38.0 million of dividends;

• received $23.3 million of additional net borrowings on our revolving line

of credit;

• paid $1.9 million on mortgage notes payable that are non-recourse to us;

• paid $467,000 of financing costs related to the revolving credit agreement,

including amendment fees, and;

• paid $235,000 to repurchase shares of our common stock in connection with

income tax withholding obligations related to stock-based compensation.




2019:

The $25.1 million of cash used in financing activities during 2019 consisted of:

• received $16.6 million of additional net borrowings on our revolving line

of credit;

• received $211,000 of net cash from the issuance of shares of beneficial

interest;

• paid $221,000 to repurchase shares of our common stock in connection with

income tax withholding obligations related to stock-based compensation;




  • paid $37.4 million of dividends;




                                       45

--------------------------------------------------------------------------------


     •  paid $4.2 million on mortgage notes payable that are non-recourse to us,
        including the repayment of $2.5 million related to a previously
        outstanding mortgage note payable on one property that was funded
        utilizing borrowings under our revolving credit agreement, and;


  • paid $35,000 of financing costs.

Year ended December 31, 2019 as compared to December 31, 2018:

Net cash provided by operating activities

Net cash provided by operating activities was $42.7 million during 2019 as compared to $42.9 million during 2018. The $275,000 decrease was attributable to:

• an unfavorable change of approximately $1.6 million due to a decrease in

net income plus/minus the adjustments to reconcile net income to net cash

provided by operating activities (depreciation and amortization,

amortization of debt premium, stock-based compensation, hurricane insurance

recovery proceeds in excess of damaged property write-downs and gains on

sales of real estate assets), as discussed above. This decrease was due

primarily to $1.7 million of income recorded during 2018 in connection a


       lease termination agreement on a single-tenant MOB located in Texas, that
       terminated a lease that was scheduled to expire in July, 2020;

• an unfavorable change of $1.8 million in tenant reserves, deposits and

deferred and prepaid rents, primarily resulting from cash received in 2018


       from various tenants as reimbursement for their share of the cost of
       certain tenant improvements;


  • a favorable change of $711,000 in lease and other receivables;


  • a favorable change of $299,000 in leasing costs paid;


    •  a favorable change of $1.3 million in accrued expenses and other
       liabilities due to timing of disbursements, and;


  • other combined net favorable changes of $796,000.



Net cash used in investing activities



Net cash used in investing activities was $16.5 million during 2019 as compared
to $8.0 million during 2018. The factors contributing to the $16.5 million of
net cash used in investing activities during 2019 are detailed above.

2018:

During 2018, $8.0 million of net cash was used in investing activities as follows:

• spent $820,000 to fund equity investments in various unconsolidated LLCs;

• spent approximately $8.3 million for additions to real estate investments,


        consisting primarily of hurricane related repairs at certain MOBs and
        tenant improvements at various MOBs;

• spent approximately $4.1 million to acquire the Beaumont Medical Sleep

Center Building, as discussed in Note 3 to the consolidated financial


        statements - New Construction, Acquisitions and Dispositions;


  • spent $192,000 for hurricane related remediation expenses;

• received $834,000 of cash distributions in excess of income received from

our unconsolidated LLCs ($2.6 million of cash distributions received less

$1.8 million of equity in income of unconsolidated LLCs), and;

• received approximately $4.5 million of hurricane insurance proceeds in


        excess of damaged property write-downs.



Net cash used in financing activities



Net cash used in financing activities was $25.1 million during 2019, as compared
to $33.3 million during 2018. The factors contributing to the $25.1 million of
net cash used in financing activities during 2019 are detailed above.

2018:

The $33.3 million of cash used in financing activities during 2018 consisted of:

• received $15.4 million of additional net borrowings on our revolving line

of credit;

• received $13.0 million of proceeds related to a new mortgage note payable

refinancing that are non-recourse to us (these proceeds were utilized to


        repay outstanding borrowings under our revolving credit facility);




                                       46

--------------------------------------------------------------------------------

• received $229,000 of net cash from the issuance of shares of beneficial


        interest;


  • paid $36.8 million of dividends;

• repaid $23.4 million on mortgage notes payable that are non-recourse to us


        (one of which was subsequently refinanced with a new $13.0 million
        mortgage), and;


     •  paid $1.7 million of financing costs related to the revolving credit
        agreement and a new mortgage note payable that is non-recourse to us.

Additional cash flow and dividends paid information for 2020, 2019 and 2018:



As indicated on our consolidated statements of cash flows, we generated net cash
provided by operating activities of $44.2 million during 2020, $42.7 million
during 2019 and $42.9 million during 2018. As also indicated on our statements
of cash flows, non-cash expenses including depreciation and amortization
expense, amortization related to above/below market leases, amortization of debt
premium, amortization of deferred financing costs, stock-based compensation,
hurricane insurance recovery proceeds in excess of damaged property write-downs
(as applicable) and gains on sales of real estate assets (as applicable), are
the primary differences between our net income and net cash provided by
operating activities for each year.

We declared and paid dividends of $38.0 million during 2020, $37.4 million
during 2019 and $36.8 million during 2018. During 2020, the $44.2 million of net
cash provided by operating activities was approximately $6.2 million greater
than the $38.0 million of dividends paid during 2020. During 2019, the $42.7
million of net cash provided by operating activities was approximately $5.2
million greater than the $37.4 million of dividends paid during 2019. During
2018, the $42.9 million of net cash provided by operating activities was
approximately $6.1 million greater than the $36.8 million of dividends paid
during 2018.

As indicated in the cash flows from investing activities and cash flows from
financing activities sections of the statements of cash flows, there were
various other sources and uses of cash during each of the last three years. From
time to time, various other sources and uses of cash may include items such as
investments and advances made to/from LLCs, additions to real estate
investments, acquisitions/divestiture of properties, net borrowings/repayments
of debt, and proceeds generated from the issuance of equity. Therefore, in any
given period, the funding source for our dividend payments is not wholly
dependent on the operating cash flow generated by our properties. Rather, our
dividends as well as our capital reinvestments into our existing properties,
acquisitions of real property and other investments are funded based upon the
aggregate net cash inflows or outflows from all sources and uses of cash from
the properties we own either in whole or through LLCs, as outlined above.

In determining and monitoring our dividend level on a quarterly basis, our
management and Board of Trustees consider many factors in determining the amount
of dividends to be paid each period. These considerations primarily include:
(i) the minimum required amount of dividends to be paid in order to maintain our
REIT status; (ii) the current and projected operating results of our properties,
including those owned in LLCs, and; (iii) our future capital commitments and
debt repayments, including those of our LLCs. Based upon the information
discussed above, as well as consideration of projections and forecasts of our
future operating cash flows, management and the Board of Trustees have
determined that our operating cash flows have been sufficient to fund our
dividend payments. Future dividend levels will be determined based upon the
factors outlined above with consideration given to our projected future results
of operations.

We expect to finance all capital expenditures and acquisitions and pay dividends
utilizing internally generated and additional funds. Additional funds may be
obtained through: (i) borrowings under our existing $350 million revolving
credit agreement (which had $108.2 million of available borrowing capacity, net
of outstanding borrowings and letters of credit as of December 31, 2020);
(ii) borrowings under or refinancing of existing third-party debt pursuant to
mortgage loan agreements entered into by our consolidated and unconsolidated
LLCs/LPs; (iii) the issuance of equity pursuant to our at-the-market ("ATM")
equity issuance program, and/or; (iv) the issuance of other long-term debt.

We believe that our operating cash flows, cash and cash equivalents, available
borrowing capacity under our revolving credit agreement and access to the
capital markets provide us with sufficient capital resources to fund our
operating, investing and financing requirements for the next twelve months,
including providing sufficient capital to allow us to make distributions
necessary to enable us to continue to qualify as a REIT under Sections 856 to
860 of the Internal Revenue Code of 1986. In the event we need to access the
capital markets or other sources of financing, there can be no assurance that we
will be able to obtain financing on acceptable terms or within an acceptable
time. Our inability to obtain financing on terms acceptable to us could have a
material unfavorable impact on our results of operations, financial condition
and liquidity.



                                       47

--------------------------------------------------------------------------------

Credit facilities and mortgage debt



Management routinely monitors and analyzes the Trust's capital structure in an
effort to maintain the targeted balance among capital resources including the
level of borrowings pursuant to our $350 million revolving credit facility, the
level of borrowings pursuant to non-recourse mortgage debt secured by the real
property of our properties and our level of equity including consideration of
additional equity issuances pursuant to our ATM equity issuance program. This
ongoing analysis considers factors such as the current debt market and interest
rate environment, the current/projected occupancy and financial performance of
our properties, the current loan-to-value ratio of our properties, the Trust's
current stock price, the capital resources required for anticipated acquisitions
and the expected capital to be generated by anticipated divestitures. This
analysis, together with consideration of the Trust's current balance of
revolving credit agreement borrowings, non-recourse mortgage borrowings and
equity, assists management in deciding which capital resource to utilize when
events such as refinancing of specific debt components occur or additional funds
are required to finance the Trust's growth.

In June 2020, we entered into the first amendment (the "First Amendment") to the
revolving credit agreement ("Credit Agreement"), pursuant to which, among other
things, an additional tranche of revolving credit commitments in the amount of
$50 million, designated as the "Revolving B Facility", was established thereby
increasing the aggregate revolving credit commitment to $350 million from $300
million. The Credit Agreement, as amended, which is scheduled to mature in March
2022, provides for a revolving credit facility in an aggregate principal amount
of $350 million, including a $40 million sublimit for letters of credit and a
$30 million sublimit for swingline/short-term loans. Borrowings under the Credit
Agreement are guaranteed by certain subsidiaries of the Trust. In addition,
borrowings under the Credit Agreement are secured by first priority security
interests in and liens on all equity interests in certain of the Trust's
wholly-owned subsidiaries. The remainder of the revolving credit commitments
provided under the Credit Agreement that were in effect prior to giving effect
to the First Amendment, has been designated as the "Revolving A Facility".

Borrowings made pursuant to the Revolving A Facility will bear interest, at our
option, at one, two, three or six-month LIBOR plus an applicable margin ranging
from 1.10% to 1.35% or at the Base Rate plus an applicable margin ranging from
0.10% to 0.35%. The Credit Agreement defines "Base Rate" as the greater of:
(a) the administrative agent's prime rate; (b) the federal funds effective rate
plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. A facility fee of 0.15% to
0.35% will be charged on the total commitment of the Revolving A Facility of the
Credit Agreement. The margins over LIBOR, Base Rate and the facility fee are
based upon our total leverage ratio. At December 31, 2020, the applicable margin
over the LIBOR rate was 1.20%, the margin over the Base Rate was 0.20%, and the
facility fee was 0.20%. The Credit Agreement also provides for options to extend
the maturity date and borrowing availability for two additional six-month
periods for the Revolving A Facility.

Borrowings made pursuant to the Revolving B Facility will bear interest, at our
option, at one, two, three or six months LIBOR plus an applicable margin ranging
from 1.85% to 2.10% or at the Base Rate plus an applicable margin ranging from
0.85% to 1.10%. The Credit Agreement defines "Base Rate" as the greatest of
(a) the administrative agent's prime rate; (b) the federal funds effective rate
plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. The initial applicable margin
is 1.95% for LIBOR loans and 0.95% for Base Rate loans. A facility fee of 0.15%
to 0.35% will be charged on the total commitment of the Revolving B Facility of
the Credit Agreement. The margins over LIBOR, Base Rate and the facility fee are
based upon our total leverage ratio. At December 31, 2020, the applicable margin
over the LIBOR rate was 1.95%, the margin over the Base Rate was 0.95% and the
facility fee was 0.20%.

At December 31, 2020, we had $236.2 million of outstanding borrowings and $5.6
million of letters of credit outstanding under our Credit Agreement. We had
$108.2 million of available borrowing capacity, net of the outstanding
borrowings and letters of credit outstanding as of December 31, 2020. The
carrying amount and fair value of borrowings outstanding pursuant to the Credit
Agreement was $236.2 million at December 31, 2020. There are no compensating
balance requirements. The average amount outstanding under our Credit Agreement
during the years ended December 31, 2020, 2019 and 2018 was $219.1 million,
$198.3 million and $191.4 million, respectively, with corresponding effective
interest rates of 2.4%, 3.7% and 3.5%, respectively, including commitment fees
and interest rate swaps/caps.  At December 31, 2019, we had $213.0 million of
outstanding borrowings outstanding against our revolving credit agreement and
$87.0 million of available borrowing capacity.

The Credit Agreement contains customary affirmative and negative covenants,
including limitations on certain indebtedness, liens, acquisitions and other
investments, fundamental changes, asset dispositions and dividends and other
distributions. The Credit Agreement also contains restrictive covenants
regarding the Trust's ratio of total debt to total assets, the fixed charge
coverage ratio, the ratio of total secured debt to total asset value, the ratio
of total unsecured debt to total unencumbered asset value, and minimum tangible
net worth, as well as customary events of default, the occurrence of which may
trigger an acceleration of amounts outstanding under the Credit Agreement. We
are in compliance with all of the covenants at December 31, 2020 and 2019. We
also believe that we would remain in compliance if, assuming that the majority
of the potential new borrowings will be used to fund investments, the full
amount of our commitment was borrowed.



                                       48

--------------------------------------------------------------------------------


The following table includes a summary of the required compliance ratios at
December 31, 2020 and 2019, giving effect to the covenants contained in the
Credit Agreements in effect on the respective dates (dollar amounts in
thousands):

                            December 31, 2020           December 31, 2019
                        Covenant         UHT        Covenant         UHT
Tangible net worth      $ 125,000     $ 147,263     $ 125,000     $ 167,181
Total leverage               < 60 %        44.8 %        < 60 %        42.3 %
Secured leverage             < 30 %         8.6 %        < 30 %         9.1 %
Unencumbered leverage        < 60 %        41.4 %        < 60 %        38.5 %
Fixed charge coverage     > 1.50x          4.7x       > 1.50x          4.0x




As indicated on the following table, we have various mortgages, all of which are
non-recourse to us and are not cross-collateralized, included on our
consolidated balance sheet as of December 31, 2020 and 2019 (amounts in
thousands):



                                                            As of 12/31/2020                          As of 12/31/2019
                                                                               Outstanding              Outstanding
                                           Interest         Maturity             Balance                  Balance
Facility Name                                Rate             Date          (in thousands)(a.)         (in thousands)
700 Shadow Lane and Goldring MOBs fixed
rate
  mortgage loan                                 4.54 %        June, 2022                  5,437                   5,654
BRB Medical Office Building fixed rate
mortgage loan                                   4.27 %    December, 2022                  5,505                   5,721
Desert Valley Medical Center fixed rate
mortgage loan                                   3.62 %     January, 2023                  4,511                   4,661
2704 North Tenaya Way fixed rate
mortgage loan                                   4.95 %    November, 2023                  6,576                   6,727
Summerlin Hospital Medical Office
Building III fixed
  rate mortgage loan                            4.03 %       April, 2024                 13,043                  13,196
Tuscan Professional Building fixed rate
mortgage loan                                   5.56 %        June, 2025                  2,933                   3,492
Phoenix Children's East Valley Care
Center fixed rate
  mortgage loan                                 3.95 %     January, 2030                  8,718                   8,961
Rosenberg Children's Medical Plaza
fixed rate mortgage loan                        4.42 %   September, 2033                 12,508                  12,732
Total, excluding net debt premium and
net financing fees                                                                       59,231                  61,144
  Less net financing fees                                                                  (477 )                  (594 )
  Plus net debt premium                                                                     141                     194
Total mortgage notes payable,
non-recourse to us, net                                                    $             58,895      $           60,744



(a.) All mortgage loans require monthly principal payments through maturity and

either fully amortize or include a balloon principal payment upon

maturity.




The mortgages are secured by the real property of the buildings as well as
property leases and rents. The mortgages outstanding as of December 31, 2020 had
a combined carrying value of approximately $59.2 million and a combined fair
value of approximately $62.0 million. At December 31, 2019, we had various
mortgages, all of which were non-recourse to us, included in our consolidated
balance sheet. The combined outstanding balance of these various mortgages was
$61.1 million and these mortgages had a combined fair value of approximately
$63.1 million.

The fair value of our debt was computed based upon quotes received from
financial institutions. We consider these to be "level 2" in the fair value
hierarchy as outlined in the authoritative guidance for disclosure in connection
with debt instruments. Changes in market rates on our fixed rate debt impacts
the fair value of debt, but it has no impact on interest incurred or cash flow.













                                       49

--------------------------------------------------------------------------------

Contractual Obligations:



The following table summarizes the schedule of maturities of our outstanding
borrowing under our revolving credit facility ("Credit Agreement"), the
outstanding mortgages applicable to our properties recorded on a consolidated
basis and our other contractual obligations as of December 31, 2020 (amounts in
thousands):



                                                   Payments Due by Period (dollars in thousands)
                                                    Less than                                      More than
Debt and Contractual Obligation         Total         1 Year       1-3 years       3-5 years        5 years
Long-term non-recourse debt-fixed
(a) (b)                               $  59,231     $    2,081     $   24,089     $    14,489     $    18,572
Long-term debt-variable (c)             236,200              -        236,200               -               -
Estimated future interest payments
on debt outstanding as
  of December 31, 2020 (d)               16,779          5,710          4,761           1,835           4,473
Operating leases (e)                     27,361            480            960             960          24,961
Construction commitments (f)             12,097         12,097              -               -               -
Equity and debt financing
commitments (g)                             362            362              -               -               -

Total contractual obligations $ 352,030 $ 20,730 $ 266,010 $ 17,284 $ 48,006

(a) The mortgages are secured by the real property of the buildings as well as

property leases and rents. Property-specific debt is detailed above.

(b) Consists of non-recourse debt with an aggregate fair value of approximately

$62.0 million as of December 31, 2020. Changes in market rates on our fixed

rate debt impacts the fair value of debt, but it has no impact on interest

incurred or cash flow. Excludes $39.7 million of combined third-party debt


    outstanding as of December 31, 2020, that is non-recourse to us, at the
    unconsolidated LLCs in which we hold various non-controlling ownership
    interests (see Note 8 to the consolidated financial statements).

(c) Consists of $236.2 million of borrowings outstanding as of December 31, 2020


    under the terms of our $350 million Credit Agreement which matures on
    March 28, 2022. The amount outstanding approximates fair value as of
    December 31, 2020.

(d) Assumes that all debt outstanding as of December 31, 2020, including

borrowings under the Credit Agreement, and the loans which are non-recourse

to us, remain outstanding until the stated maturity date of the debt

agreements at the same interest rates which were in effect as of December 31,

2020. We have the right to repay borrowings under the Credit Agreement at any

time during the term of the agreement, without penalty. Interest payments are

expected to be paid utilizing cash flows from operating activities or

borrowings under our revolving Credit Agreement.

(e) Reflects our future minimum operating lease payment obligations outstanding

as of December 31, 2020, as discussed in Note 4 to the consolidated financial

statements -Lease Accounting, in connection with ground leases at fourteen of

our consolidated properties.

(f) Consists of the remaining estimated construction costs of two new

construction projects, consisting of a 100-bed behavioral health care

facility located in Clive, Iowa, and a 75,000 rentable square foot MOB

located in Denison, Texas, both of which are were substantially completed in

late 2020. We are required to build these facilities pursuant to agreements

with third parties.

(g) Consists of equity investment and debt financing commitments remaining in

connection with our investment at Forney Medical Plaza II.

Off Balance Sheet Arrangements



As of December 31, 2020 we are party to certain off balance sheet arrangements
consisting of standby letters of credit and equity and debt financing
commitments. Our outstanding letters of credit at December 31, 2020 totaled $5.6
million related to Grayson Properties II. As of December 31, 2019, we did not
have any off balance sheet arrangements other than equity and debt financing
commitments.

Acquisition and Divestiture Activity

Please see Note 3 to the consolidated financial statements for completed transactions.

© Edgar Online, source Glimpses